PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
35.84%
Revenue growth exceeding 1.5x Insurance - Life median of 1.21%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
35.84%
Gross profit growth exceeding 1.5x Insurance - Life median of 1.63%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
58.74%
EBIT growth of 58.74% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
58.74%
Operating income growth exceeding 1.5x Insurance - Life median of 2.92%. Joel Greenblatt would see if unique processes drive exceptional profitability.
59.48%
Positive net income growth while Insurance - Life median is negative. Peter Lynch would view this as a notable competitive advantage.
59.50%
Positive EPS growth while Insurance - Life median is negative. Peter Lynch might see a strong advantage in per-share earnings compared to peers.
59.48%
Positive diluted EPS growth while Insurance - Life median is negative. Peter Lynch might see a real advantage in how this firm manages share count or drives net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.35%
Negative OCF growth while Insurance - Life median is -1.35%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-1.35%
Negative FCF growth while Insurance - Life median is -1.35%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
117.56%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 51.81%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
636.24%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 56.31%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
162.88%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 32.74%. Joel Greenblatt might see a short-term competitive advantage at play.
118.45%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 0.87% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
39.57%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 4.23%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
42.25%
3Y OCF/share growth of 42.25% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
3026.09%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 98.92% over a decade. Joel Greenblatt might see a standout compounder of earnings.
1321.83%
5Y net income/share CAGR > 1.5x Insurance - Life median of 105.49%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
559.80%
3Y net income/share CAGR > 1.5x Insurance - Life median of 29.50%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
133.71%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
35.87%
5Y equity/share CAGR 75-90% of Insurance - Life median. John Neff calls for higher returns or more efficient buybacks to match peers.
24.14%
3Y equity/share CAGR 50-75% of Insurance - Life median. Guy Spier suspects suboptimal short-term capital usage vs. peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.59%
AR growth of 6.59% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
2.15%
Asset growth exceeding 1.5x Insurance - Life median of 0.58%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
5.22%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
-0.24%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
5.04%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.